LHC Group, Inc. (NASDAQ:LHCG) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $149.80 and last traded at $149.47, with a volume of 20047 shares changing hands. The stock had previously closed at $146.64.
LHCG has been the topic of several recent research reports. SunTrust Banks upped their target price on shares of LHC Group from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Friday, December 6th. Stephens initiated coverage on shares of LHC Group in a research report on Monday, October 21st. They set an “overweight” rating and a $132.00 target price on the stock. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $145.00 target price on the stock in a research report on Monday, January 6th. William Blair restated an “outperform” rating on shares of LHC Group in a research report on Thursday, November 7th. Finally, BidaskClub upgraded shares of LHC Group from a “buy” rating to a “strong-buy” rating in a research report on Thursday, January 23rd. Four research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. LHC Group has a consensus rating of “Buy” and an average target price of $134.82.
The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.20. The company has a market capitalization of $4.62 billion, a PE ratio of 48.84, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. The stock’s 50-day moving average is $139.31 and its two-hundred day moving average is $125.85.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.26 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.18. LHC Group had a net margin of 4.59% and a return on equity of 9.39%. The company had revenue of $528.50 million for the quarter, compared to analyst estimates of $534.15 million. During the same period in the prior year, the company posted $0.95 EPS. The firm’s revenue for the quarter was up 4.2% on a year-over-year basis. On average, equities research analysts forecast that LHC Group, Inc. will post 4.46 EPS for the current fiscal year.
A number of institutional investors have recently bought and sold shares of LHCG. Synovus Financial Corp raised its position in LHC Group by 130.8% in the 3rd quarter. Synovus Financial Corp now owns 300 shares of the health services provider’s stock worth $34,000 after purchasing an additional 170 shares during the period. Tower Research Capital LLC TRC purchased a new stake in LHC Group in the 2nd quarter worth about $39,000. Quest Capital Management Inc. ADV purchased a new position in shares of LHC Group during the third quarter worth approximately $147,000. BB&T Securities LLC purchased a new position in shares of LHC Group during the third quarter worth approximately $204,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of LHC Group by 12.9% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,804 shares of the health services provider’s stock worth $205,000 after acquiring an additional 206 shares during the period. 92.77% of the stock is currently owned by institutional investors.
LHC Group Company Profile (NASDAQ:LHCG)
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Featured Article: Current Ratio
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.